La startup de ciencias biológicas de Durham, Shattuck Labs, se hace pública y recauda $202M
Fecha de publicación:DURHAM – Laboratorios Shattuck, a life science startup focusing on development of new treatments for cancer and autoimmune disease, is going public today and expects to raise $202 million the process.
The company in June closed on $118 million in new financing and secured Durham-based Hatteras Venture Partners as a backer.
In an announcement made late Thursday, Shattuck said shares would begin trading today on the Nasdaq under the symbol “STTK.”
Shares were priced at $17.
Some 11,882,352 shares were issued with underwriters having the option to purchase another 1.8 million shares.
The company has offices in Durham and Austin, Texas.
Fuente del artículo original: WRAL TechWire